LightDark Log in Sign up

‹ Back to screener

WOCKPHARMA.NS Wockhardt Ltd.

Healthcare

Price history

1M 6M 1Y 3Y Max
2026-07-22 ₹1861.50
2026-08-21 ₹1894.90
Change over window +1.79%

Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.

Technical indicators

ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.

MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.

Delivery volume

Latest (2026-08-28) 34.5%
Trailing 20-day average 42.4%
Date Traded Qty Delivery Qty Delivery %
2026-08-28 1581060 545139 34.48%
2026-08-27 1210241 461171 38.11%
2026-08-26 310259 118979 38.35%
2026-08-25 241579 95178 39.40%
2026-08-24 306988 126317 41.15%
2026-08-21 559221 252545 45.16%
2026-08-20 258015 111266 43.12%
2026-08-19 503577 259591 51.55%
2026-08-18 476558 264454 55.49%
2026-08-17 342549 169166 49.38%
2026-08-14 480219 177131 36.89%
2026-08-13 742285 288864 38.92%
2026-08-12 577896 299649 51.85%
2026-08-11 1073711 326103 30.37%
2026-08-10 1702030 559878 32.89%
2026-08-07 547985 260033 47.45%
2026-08-06 578202 230222 39.82%
2026-08-05 863920 397435 46.00%
2026-08-04 787321 308640 39.20%
2026-08-03 1182004 582260 49.26%

Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers WOCKPHARMA.NS to fetch more history.

Insider trading activity

Disclosed Person Category Type Mode Quantity Value (₹) Resulting stake
27 Dec 2024 Muayyad Khorakiwala Immediate relative Buy Gift 1800 0 0.00% XBRL
11 Mar 2022 Themisto Trustee Company Private Limited Promoters Pledge Pledge Creation 1740000 544881000 53.69% XBRL
01 Mar 2022 Themisto Trustee Company Private Limited Promoters Pledge Pledge Creation 5220000 1776516500 53.69% XBRL
28 Dec 2021 Themisto Trustee Company Private Limited Promoter Group Pledge Pledge Creation 1900000 748505000 53.69% XBRL
02 Dec 2021 Themisto Trustee Company Private Limited Promoter Group Pledge Pledge Creation 400000 174220000 53.69% XBRL
26 Oct 2021 Themisto Trustee Company Private Limited Promoter Group Pledge Pledge Creation 1350000 624105000 53.69% XBRL
11 Oct 2021 Themisto Trustee Company Private Limited Promoter Group Pledge Revoke Revokation of Pledge 98000 47069400 53.69% XBRL
03 Sep 2021 Themisto Trustee Company Private Limited Promoter Group Pledge Pledge Creation 190000 79838000 53.69% XBRL
03 Sep 2021 Themisto Trustee Company Private Limited Promoter Group Pledge Pledge Creation 1240000 499814000 53.69% XBRL
01 Sep 2021 Themisto Trustee Company Private Limited Promoter Group Sell Market Sale 500000 216319366 53.69% XBRL
01 Sep 2021 Themisto Trustee Company Private Limited Promoter Group Sell Market Sale 500000 220707704 2.98% XBRL
01 Sep 2021 Pasithee Trustee Company Private Limited Promoter Group Sell Market Sale 500000 202951839 0.45% XBRL
01 Sep 2021 Ananke Trustee Company Private Limited Promoter Group Sell Market Sale 300000 119733444 0.61% XBRL
31 Aug 2021 Akhilesh Gupta Director Buy Market Purchase 10000 4393339 0.01% XBRL
31 Aug 2021 Themisto Trustee Company Private Limited Promoter Group Pledge Pledge Creation 400000 166180000 53.69% XBRL
27 Aug 2021 Themisto Trustee Company Private Limited Promoter Group Pledge Pledge Creation 2227000 992718250 54.15% XBRL
20 Aug 2021 Themisto Trustee Company Private Limited Promoter Group Pledge Pledge Creation 30000 14656500 54.15% XBRL
16 Aug 2021 Themisto Trustee Company Private Limited Promoter Group Pledge Pledge Creation 1000000 477650000 54.16% XBRL
26 Jul 2021 Themisto Trustee Company Private Limited Promoter Group Pledge Revoke Revokation of Pledge 100000 55760000 54.16% XBRL
22 Jul 2021 Themisto Trustee Company Private Limited Promoter Group Pledge Revoke Revokation of Pledge 150000 87127500 54.16% XBRL

SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers WOCKPHARMA.NS to fetch more.

Ratios as of FY2025-26 (Annual) · Price ₹1886.30 INR (live) · fetched 2026-08-24 01:46 price stale

Extract this company (financials + ratios + citations): CSV · XLSX

Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score

Ratios

P/E
143.47
P/E = Price / EPS
Source trace
P/E = Price / (ProfitOrLossAttributableToOwnersOfParent / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) → ₹1,886.30 / (₹2,130,000,000 / 162,000,000 shares) = ₹1,886.30 / ₹13.15 EPS
FY2025-26 · Annual filing
ROE
4.31%
ROE = Net Income / Shareholder Equity
Source trace
ROE = ProfitOrLossAttributableToOwnersOfParent / EquityAttributableToOwnersOfParent → ₹2,130,000,000 / ₹49,400,000,000 = 4.31%
FY2025-26 · Annual filing
Debt/Equity
0.43
Debt/Equity = Total Debt / Shareholder Equity
Source trace
Debt/Equity = BorrowingsCurrent + BorrowingsNoncurrent / EquityAttributableToOwnersOfParent → ₹21,250,000,000 / ₹49,400,000,000 = 0.43
FY2025-26 · Annual filing
Current Ratio
1.61
Current Ratio = Current Assets / Current Liabilities
Source trace
Current Ratio = CurrentAssets / CurrentLiabilities → ₹26,060,000,000 / ₹16,220,000,000 = 1.61
FY2025-26 · Annual filing
ROCE
7.59%
ROCE = EBIT / (Shareholder Equity + Total Debt)
Source trace
ROCE = ProfitBeforeExceptionalItemsAndTax + FinanceCosts / (EquityAttributableToOwnersOfParent + BorrowingsCurrent + BorrowingsNoncurrent) → ₹5,360,000,000 / (₹49,400,000,000 + ₹21,250,000,000) = 7.59%
FY2025-26 · Annual filing
Dividend Yield
0.00%
Dividend Yield = (Dividends Paid / Diluted Shares Outstanding) / Price

This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.

Source trace
Dividend Yield = (|DividendsPaidClassifiedAsFinancingActivities| / PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital) / Price → (₹0 / 162,000,000 shares) / ₹1,886.30 = ₹0.00 / ₹1,886.30
FY2025-26 · Annual filing

Growth & earnings trend

Revenue & Profit CAGR

Revenue (3y, 3.0y actual) 8.4%
Net Profit (3y) N/A
Revenue (5y, 3.0y actual) 8.4%
Net Profit (5y) N/A
Revenue (10y, 3.0y actual) 8.4%
Net Profit (10y) N/A

Operating Margin Trend

Expanding

FY2022-23 -1.1%
FY2023-24 -3.6%
FY2024-25 7.9%
FY2025-26 15.9%

ROCE Trajectory

FY2022-23 -0.5%
FY2023-24 -1.7%
FY2024-25 3.7%
FY2025-26 7.2%

Earnings Quality

Net profit or operating cash flow was zero or negative in the base or latest year — a growth-rate comparison isn't defined across a sign change.

Sector-Relative Percentile (Healthcare)

ROE 9th
ROCE 9th
Debt/Equity 22th
P/E 4th

Quarterly trend

Revenue Net Profit Net Profit (loss quarter)
Metric (to shareholders basis) Q4 FY2023-24 Q1 FY2024-25 Q2 FY2024-25 Q3 FY2024-25 Q4 FY2024-25 Q1 FY2025-26 Q2 FY2025-26 Q3 FY2025-26 Q4 FY2025-26 Q1 FY2026-27 Source
Revenue ₹700.00 Cr. ₹739.00 Cr. ₹809.00 Cr. ₹721.00 Cr. ₹743.00 Cr. ₹738.00 Cr. ₹782.00 Cr. ₹888.00 Cr. ₹965.00 Cr. ₹929.00 Cr. RevenueFromOperations
Net Profit ₹-169.00 Cr. incl. minority ₹-177.00 Cr. ₹-14.00 Cr. incl. minority ₹-16.00 Cr. ₹-22.00 Cr. incl. minority ₹-16.00 Cr. ₹14.00 Cr. incl. minority ₹20.00 Cr. ₹-25.00 Cr. incl. minority ₹-45.00 Cr. ₹-90.00 Cr. incl. minority ₹-108.00 Cr. ₹78.00 Cr. incl. minority ₹82.00 Cr. ₹59.00 Cr. incl. minority ₹61.00 Cr. ₹166.00 Cr. incl. minority ₹164.00 Cr. ₹106.00 Cr. incl. minority ₹107.00 Cr. ProfitOrLossAttributableToOwnersOfParent

Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers WOCKPHARMA.NS to fetch more.

Source document — income statement (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

ProfitOrLossAttributableToOwnersOfParent2130000000.0
PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital162000000.0
Source document — balance sheet (FY2025-26, raw filing line items)

View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.

CurrentAssets26060000000.0
CurrentLiabilities16220000000.0
EquityAttributableToOwnersOfParent49400000000.0
BorrowingsCurrent + BorrowingsNoncurrent21250000000.0

My notes